Sign in

CIK 0001557746

  • Non-accelerated filer
  • Smaller reporting company

Aclaris Therapeutics, Inc.

Sign in to watch
Ticker
ACRS
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
Dec 31
Incorporated
DE
Entity type
Operating
EIN
460571712
Phone
+1 484-324-7933
Business address
701 LEE ROAD, SUITE 103, WAYNE, PA, 19087
  1. 4 Open-market buy Pres and CEO bought 6,500 shares at $7.74 ($50,278)
  2. 4 Open-market sale Director sold 59,240 shares at an average $12.50 ($740,658)
  3. 4 Open-market sale Chief Scientific Officer sold 30,837 shares at an average $12.51 ($385,639)
  4. 4 Open-market sale Chief Financial Officer sold 1,894 shares at an average $12.45 ($23,579)
  5. 4 Open-market sale Chief Scientific Officer sold 5,000 shares at $13.06 ($65,311)
  6. 4 Open-market sale Chief Business Officer sold 4,267 shares at $13.89 ($59,272)
  7. 4 Open-market sale Director sold 30,000 shares at an average $16.66 ($499,923)
  8. 4 Derivatives Options or other derivatives
  9. 4 Derivatives Options or other derivatives
  10. 4 Exercise or conversion Chief Business Officer acquired 11,250 shares (option exercise)
  11. 4 Derivatives Options or other derivatives
  12. 4 Derivatives Options or other derivatives
  13. 4 Gift Director gave 4,000 shares (gift)
  14. 3 Insider Initial Statement of Ownership
  15. 4 Open-market sale Director sold 40,000 shares at an average $15.11 ($604,556)
  16. 4 Open-market sale Chief Scientific Officer sold 5,000 shares at $15.88 ($79,412)
  17. 4 Open-market sale Director sold 53,926 shares at an average $17.05 ($919,589)
  18. 4 Open-market sale Director sold 41,174 shares at an average $17.01 ($700,355)
  19. 4 Open-market sale Director sold 52,037 shares at an average $16.57 ($862,109)
  20. 4 Open-market sale Chief Scientific Officer sold 5,000 shares at $15.98 ($79,908)

Page 7 of 21 · 414 filings